ORBIMED ADVISORS LLC

PrivateCIK: 1055951
Location

NEW YORK, NY

ORBIMED ADVISORS LLC sold 104.66K shares of ADICET BIO, INC. on the open market

Open‑market sale worth $674.8K. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales
InsiderORBIMED ADVISORS LLCCIK 1055951
→
IssuerADICET BIO, INC.CIK 1720580
Director10% Owner
Since Sep 2020
-104.66K
Net shares
Net seller
$674.8K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
104.66K disposed
Non-Derivative Transactions4

Common Stock

Indirect
S · Sale

Shares

−29.32K

Price / share

$6.53

Trade value

$191.45K

% of position

45.6%
4/7/2026
64.24K→34.92K

Common Stock

Indirect
S · Sale

Shares

−2.40K

Price / share

$6.38

Trade value

$15.31K

% of position

6.9%
4/7/2026
34.92K→32.52K

Common Stock

Indirect
S · Sale

Shares

−32.52K

Price / share

$6.29

Trade value

$204.57K

% of position

New position
4/8/2026
32.52K→0.00

Common Stock

Indirect
S · Sale

Shares

−40.42K

Price / share

$6.52

Trade value

$263.51K

% of position

New position
4/8/2026
40.42K→0.00
Total

Net shares

−104.66K

Net value

-$674.85K

Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3

Common Stock

Indirect
Shares owned280.64K

Common Stock

Indirect
Shares owned78.50K

Common Stock

Indirect
Shares owned564.15K
Total
923.29K indirect923.29K
Derivative Holdings (Post-Transaction)0
No derivative holdings reported
ORBIMED ADVISORS LLC — Insider Transaction (Form 4) Filed Apr 9, 2026 | Finecho